Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1966 1
1967 1
1968 1
1971 1
1973 1
1977 1
1980 1
1981 1
1982 2
1983 3
1984 1
1985 2
1986 7
1987 1
1988 5
1989 3
1990 3
1991 3
1992 2
1993 3
1994 4
1995 7
1997 4
1998 1
1999 5
2000 4
2001 8
2002 8
2003 25
2004 27
2005 24
2006 22
2007 25
2008 23
2009 14
2010 10
2011 15
2012 25
2013 28
2014 17
2015 19
2016 28
2017 17
2018 26
2019 21
2020 40
2021 38
2022 32
2023 19
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

540 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for and ii mazur
Search for Andrii Mazur instead (2 results)
Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
Anker SD, Butler J, Filippatos G, Ferreira JP, Bocchi E, Böhm M, Brunner-La Rocca HP, Choi DJ, Chopra V, Chuquiure-Valenzuela E, Giannetti N, Gomez-Mesa JE, Janssens S, Januzzi JL, Gonzalez-Juanatey JR, Merkely B, Nicholls SJ, Perrone SV, Piña IL, Ponikowski P, Senni M, Sim D, Spinar J, Squire I, Taddei S, Tsutsui H, Verma S, Vinereanu D, Zhang J, Carson P, Lam CSP, Marx N, Zeller C, Sattar N, Jamal W, Schnaidt S, Schnee JM, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Preserved Trial Investigators. Anker SD, et al. N Engl J Med. 2021 Oct 14;385(16):1451-1461. doi: 10.1056/NEJMoa2107038. Epub 2021 Aug 27. N Engl J Med. 2021. PMID: 34449189 Clinical Trial.
METHODS: In this double-blind trial, we randomly assigned 5988 patients with class II-IV heart failure and an ejection fraction of more than 40% to receive empagliflozin (10 mg once daily) or placebo, in addition to usual therapy. ...
METHODS: In this double-blind trial, we randomly assigned 5988 patients with class II-IV heart failure and an ejection fraction of mo …
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, Jamal W, Kimura K, Schnee J, Zeller C, Cotton D, Bocchi E, Böhm M, Choi DJ, Chopra V, Chuquiure E, Giannetti N, Janssens S, Zhang J, Gonzalez Juanatey JR, Kaul S, Brunner-La Rocca HP, Merkely B, Nicholls SJ, Perrone S, Pina I, Ponikowski P, Sattar N, Senni M, Seronde MF, Spinar J, Squire I, Taddei S, Wanner C, Zannad F; EMPEROR-Reduced Trial Investigators. Packer M, et al. N Engl J Med. 2020 Oct 8;383(15):1413-1424. doi: 10.1056/NEJMoa2022190. Epub 2020 Aug 28. N Engl J Med. 2020. PMID: 32865377 Clinical Trial.
METHODS: In this double-blind trial, we randomly assigned 3730 patients with class II, III, or IV heart failure and an ejection fraction of 40% or less to receive empagliflozin (10 mg once daily) or placebo, in addition to recommended therapy. ...
METHODS: In this double-blind trial, we randomly assigned 3730 patients with class II, III, or IV heart failure and an ejection fract …
Free radicals and antioxidants in normal physiological functions and human disease.
Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Valko M, et al. Int J Biochem Cell Biol. 2007;39(1):44-84. doi: 10.1016/j.biocel.2006.07.001. Epub 2006 Aug 4. Int J Biochem Cell Biol. 2007. PMID: 16978905 Review.
This review will describe the: (i) chemistry and biochemistry of ROS/RNS and sources of free radical generation; (ii) damage to DNA, to proteins, and to lipids by free radicals; (iii) role of antioxidants (e.g. glutathione) in the maintenance of cellular "redox homeostasis …
This review will describe the: (i) chemistry and biochemistry of ROS/RNS and sources of free radical generation; (ii) damage to DNA, …
Resistant Hypertension.
Doroszko A, Janus A, Szahidewicz-Krupska E, Mazur G, Derkacz A. Doroszko A, et al. Adv Clin Exp Med. 2016 Jan-Feb;25(1):173-83. doi: 10.17219/acem/58998. Adv Clin Exp Med. 2016. PMID: 26935512 Free article. Review.
A multidrug therapy including angiotensin - converting enzyme inhibitors, angiotensin II receptor blockers, beta blockers, diuretics, long-acting calcium channel blockers and mineralocorticoid receptor antagonists has been demonstrated to be effective in resistant hyperten …
A multidrug therapy including angiotensin - converting enzyme inhibitors, angiotensin II receptor blockers, beta blockers, diuretics, …
Structural and Thermal Investigations of Co(II) and Ni(II) Coordination Polymers Based on biphenyl-4,4'-dioxydiacetate Linker.
Głuchowska H, Łyszczek R, Mazur L, Kirillov AM. Głuchowska H, et al. Materials (Basel). 2021 Jun 25;14(13):3545. doi: 10.3390/ma14133545. Materials (Basel). 2021. PMID: 34202006 Free PMC article.
Two coordination polymers, [Co((4)-L)(H(2)O)(2)](n) (1) and [Ni(-L)(H(2)O)(4)](n) (2), were solvothermally assembled from the corresponding metal(II) chlorides and biphenyl-4,4-dioxydiacetic acid (H(2)L) as a flexible dicarboxylate linker. The cobalt(II) compound 1 …
Two coordination polymers, [Co((4)-L)(H(2)O)(2)](n) (1) and [Ni(-L)(H(2)O)(4)](n) (2), were solvothermally assembled from the corresponding …
Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF).
McMurray JJ, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau J, Shi VC, Solomon SD, Swedberg K, Zile MR; PARADIGM-HF Committees and Investigators. McMurray JJ, et al. Eur J Heart Fail. 2013 Sep;15(9):1062-73. doi: 10.1093/eurjhf/hft052. Epub 2013 Apr 5. Eur J Heart Fail. 2013. PMID: 23563576 Free PMC article. Clinical Trial.
LCZ696 belongs to a new class of drugs, the angiotensin receptor neprilysin inhibitors (ARNIs), which both block the RAAS and augment natriuretic peptides. METHODS: Patients with chronic HF, NYHA class II-IV symptoms, an elevated plasma BNP or NT-proBNP level, and an LVEF …
LCZ696 belongs to a new class of drugs, the angiotensin receptor neprilysin inhibitors (ARNIs), which both block the RAAS and augment natriu …
Copper(ii) complexes with 2-ethylpyridine and related hydroxyl pyridine derivatives: structural, spectroscopic, magnetic and anticancer in vitro studies.
Malik M, Świtlicka A, Bieńko A, Komarnicka UK, Bieńko DC, Kozieł S, Kyzioł A, Mazur T, Machura B. Malik M, et al. RSC Adv. 2022 Sep 28;12(42):27648-27665. doi: 10.1039/d2ra05133h. eCollection 2022 Sep 22. RSC Adv. 2022. PMID: 36276031 Free PMC article.
Copper(ii) complexes with 2-ethylpyridine (1 and 2), 2-(hydroxyethyl)pyridine (3) and 2-(hydroxymethyl)pyridine (4) have been synthesized and characterized. ...The geometry of the complexes 1, 3 and 4 adopts nearly perfect geometry close to square planar (1, 4) or square p …
Copper(ii) complexes with 2-ethylpyridine (1 and 2), 2-(hydroxyethyl)pyridine (3) and 2-(hydroxymethyl)pyridine (4) have been synthes …
Copper(II) Thiosemicarbazone Complexes and Their Proligands upon UVA Irradiation: An EPR and Spectrophotometric Steady-State Study.
Hricovíni M, Mazúr M, Sîrbu A, Palamarciuc O, Arion VB, Brezová V. Hricovíni M, et al. Molecules. 2018 Mar 21;23(4):721. doi: 10.3390/molecules23040721. Molecules. 2018. PMID: 29561827 Free PMC article.
Mixing of proligand solutions with the equimolar amount of copper(II) ions resulted in the formation of 1:1 Cu(II)-to-ligand complex, with the EPR and UV-Vis spectra fully compatible with those obtained for the dissolved Cu(II) thiosemicarbazone complexes. Th …
Mixing of proligand solutions with the equimolar amount of copper(II) ions resulted in the formation of 1:1 Cu(II)-to-ligand c …
540 results